HutchMED (China) LIMITED Financing Cash Flow
HutchMED (China) LIMITED (HCM) reported Financing Cash Flow of $7.84 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-03-05
- HutchMED (China) LIMITED net cash provided by (used in) financing activities for the quarter ending 2019-12-31 was $26.90M.
- HutchMED (China) LIMITED net cash provided by (used in) financing activities for the quarter ending 2019-09-30 was $1.12M, a 4562.50% increase year-over-year.
- HutchMED (China) LIMITED net cash provided by (used in) financing activities for the quarter ending 2019-06-30 was -$29.17M.
- HutchMED (China) LIMITED net cash provided by (used in) financing activities for the quarter ending 2019-03-31 was -$346.00K.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2025-12-31 | $7.84M 20-F · filed 2026-03-05 | |||
| 2025-06-30 | $9.32M 6-K · filed 2025-08-07 | |||
| 2024-12-31 | -$30.67M 20-F · filed 2026-03-05 | |||
| 2024-06-30 | -$32.56M 6-K · filed 2025-08-07 | |||
| 2023-12-31 | $48.66M 20-F · filed 2026-03-05 | |||
| 2023-06-30 | $5.83M 6-K · filed 2024-07-31 | |||
| 2022-12-31 | -$82.76M 20-F · filed 2025-03-19 | |||
| 2022-06-30 | -$74.64M 6-K · filed 2023-07-31 | |||
| 2021-12-31 | $650.03M 20-F · filed 2024-02-28 | |||
| 2021-06-30 | $578.33M 6-K · filed 2022-08-01 | |||
| 2020-12-31 | $296.43M 20-F · filed 2023-02-28 | |||
| 2020-06-30 | $96.34M 6-K · filed 2021-07-28 | |||
| 2019-12-31 | $26.90M derived: 20-F 12 month − 6-K 9 month · filed 2022-03-03 | $28.02M derived: sum of 2 quarters · filed 2022-03-03 | -$1.15M derived: sum of 3 quarters · filed 2022-03-03 | -$1.49M 20-F · filed 2022-03-03 |
| 2019-09-30 | $1.12M derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | -$28.05M derived: sum of 2 quarters · filed 2020-07-30 | -$28.40M 6-K · filed 2020-01-21 | -$28.81M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-06-30 | -$29.17M derived: 6-K 6 month − 6-K 3 month · filed 2020-07-30 | -$29.52M 6-K · filed 2020-07-30 | -$29.93M derived: sum of 3 quarters · filed 2021-03-04 | -$29.90M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-03-31 | -$346.00K 6-K · filed 2019-06-06 | -$759.00K derived: sum of 2 quarters · filed 2021-03-04 | -$735.00K derived: sum of 3 quarters · filed 2021-03-04 | -$3.35M derived: sum of 4 quarters · filed 2021-03-04 |
| 2018-12-31 | -$413.00K derived: 20-F 12 month − 6-K 9 month · filed 2021-03-04 | -$389.00K derived: sum of 2 quarters · filed 2021-03-04 | -$3.00M derived: sum of 3 quarters · filed 2021-03-04 | -$8.23M 20-F · filed 2021-03-04 |
| 2018-09-30 | $24.00K derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | -$2.59M derived: sum of 2 quarters · filed 2020-01-21 | -$7.82M 6-K · filed 2020-01-21 | |
| 2018-06-30 | -$2.61M derived: 6-K 6 month − 6-K 3 month · filed 2019-07-30 | -$7.84M 6-K · filed 2019-07-30 | ||
| 2018-03-31 | -$5.23M 6-K · filed 2019-06-06 | |||
| 2017-12-31 | $273.20M 20-F · filed 2020-03-03 | |||
| 2017-06-30 | -$1.24M 6-K · filed 2018-07-27 | |||
| 2016-12-31 | $92.44M 20-F · filed 2019-03-11 | |||
| 2016-06-30 | $88.98M 6-K · filed 2017-07-31 | |||
| 2015-12-31 | -$5.47M 20-F · filed 2018-03-12 | |||
| 2014-12-31 | -$641.00K 20-F · filed 2017-03-13 |